<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9114160</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32986</journal-id>
<journal-id journal-id-type="nlm-ta">J Dev Phys Disabil</journal-id>
<journal-id journal-id-type="iso-abbrev">J Dev Phys Disabil</journal-id>
<journal-title-group>
<journal-title>Journal of developmental and physical disabilities</journal-title>
</journal-title-group>
<issn pub-type="ppub">1056-263X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30197492</article-id>
<article-id pub-id-type="pmc">6128165</article-id>
<article-id pub-id-type="doi">10.1007/s10882-018-9590-4</article-id>
<article-id pub-id-type="manuscript">NIHMS944564</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Testing genetic modifiers of behavior and response to atomoxetine in autism spectrum disorder with ADHD</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Barrie</surname>
<given-names>Elizabeth S.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pinsonneault</surname>
<given-names>Julia K.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sadee</surname>
<given-names>Wolfgang</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hollway</surname>
<given-names>Jill A.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Handen</surname>
<given-names>Benjamin L.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smith</surname>
<given-names>Tristram</given-names>
</name>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Arnold</surname>
<given-names>L. Eugene</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Butter</surname>
<given-names>Eric</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hansen-Kiss</surname>
<given-names>Emily</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Herman</surname>
<given-names>Gail E.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aman</surname>
<given-names>Michael G.</given-names>
</name>
<xref ref-type="author-notes" rid="FN1">*</xref>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>a</label>The Ohio State University</aff>
<aff id="A2">
<label>b</label>Institute for Genomic Medicine, Nationwide Children’s Hospital</aff>
<aff id="A3">
<label>c</label>Departments of Psychiatry and Pediatrics, University of Pittsburgh School of Medicine</aff>
<aff id="A4">
<label>d</label>Department of Pediatrics, University of Rochester Medical Center</aff>
<aff id="A5">
<label>e</label>Department of Psychology, Nationwide Children’s Hospital</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding author. The Nisonger Center UCEDD, Ohio State University, 1581 Dodd Drive, Columbus, OH 43081-1257, United States, <email>aman.1@osu.edu</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p id="P63">
<bold>Authors’ Conflicts of Interest</bold>
</p>
<p id="P64">Dr. Elizabeth Barrie declares that she has no conflict of interest.</p>
<p id="P65">Ms. Emily Hansen-Kiss, LGC declares that she has no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>9</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>5</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>07</day>
<month>9</month>
<year>2018</year>
</pub-date>
<volume>30</volume>
<issue>3</issue>
<fpage>355</fpage>
<lpage>371</lpage>
<!--elocation-id from pubmed: 10.1007/s10882-018-9590-4-->
<self-uri xlink:href="https://link.springer.com/article/10.1007%2Fs10882-018-9590-4"></self-uri>
<abstract>
<sec id="S1">
<title>Background</title>
<p id="P1">Frequent non-pathogenic genetic variants may act as moderators of phenotypic severity for complex disorders such as autism spectrum disorder (ASD). We previously identified polymorphisms affecting mRNA expression of candidate genes, including tryptophan hydroxylase 2 (<italic>TPH2</italic>), dopamine beta hydroxylase (<italic>DBH</italic>), and dopamine transporter (<italic>DAT, SLC6A3</italic>).</p>
</sec>
<sec id="S2">
<title>Method</title>
<p id="P2">We compare genotypes and (1) clinical response to atomoxetine, (2) scores from the Autism Diagnostic Interview-Revised (ADI-R), and (3) severity of Attention Deficit Hyperactivity Disorder (ADHD) symptoms in a cohort of patients with ASD from multiple study sites.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">There was no association between CYP2D6 metabolizer status and atomoxetine response. <italic>TPH2</italic> rs7305115 genotype was associated with ADI-R Restrictive/Repetitive Behavior score (<italic>p</italic>=0.03). <italic>DBH</italic> rs1611115 genotype was associated with ADI-R Social score (<italic>p</italic>=0.002) and Restrictive/Repetitive Behavior score (<italic>p</italic>=0.04). The <italic>DAT</italic> intron 8 5/6 repeat was associated with ADHD symptoms (ABC Hyperactivity <italic>p</italic>=0.01 and SNAP ADHD <italic>p</italic>=0.03), replicating a previous finding.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">We find associations between ASD phenotypes and regulatory variants in catecholamine biosynthesis genes. This work may help guide future genetics studies related to ASD.</p>
</sec>
</abstract>
<kwd-group>
<kwd>autism spectrum disorder (ASD)</kwd>
<kwd>genetics</kwd>
<kwd>restrictive and repetitive behavior</kwd>
<kwd>atomoxetine (Strattera)</kwd>
<kwd>tryptophan hydroxylase 2 (<italic>TPH2</italic>)</kwd>
<kwd>dopamine transporter (<italic>DAT, SLC6A3</italic>)</kwd>
<kwd>attention deficit/hyperactivity disorder (ADHD)</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>